Logo | Name | Σ | ||
---|---|---|---|---|
Welcome to the Jungle France [Automatic translation follows] Welcome to the Jungle offers solutions to make work exciting and sustainable. At Welcome to the Jungle, we work to make work exciting and sustainable. How? By offering innovative solutions to companies so that they can develop their employer brand and strengthen their attractiveness. But also by creating an inspiring experience and content that gives workers and companies the keys to redefine the rules of work. Our job board helps digital talents explore the professional world and find the most exciting opportunities. All thanks to the wealth of our content and our thousands of job offers accessible … Sectors: Human ressources | 2095 | 1874 | 122 | |
Business France Business France is the national agency for the internationalization of the French economy. It is responsible for the international development of companies and their exports, as well as prospecting for and welcoming international investments in France. It promotes the attractiveness and business image of France, its companies and its territories. It manages and develops the V.I.E (Volontariat International en Entreprise). Created on January 1, 2015, Business France is a merger of UBIFRANCE and the AFII (French Agency for International Investments). Business France has 1,500 employees located in France and in 70 countries. It relies on a network of public and … Sectors: National and local authorities | 5213 | 3178 | 2332 | |
Leem [Automatic translation follows] The professional organization of pharmaceutical companies operating in France. Leem, Les Entreprises du médicament, brings together companies in the pharmaceutical industry sector in France. Created over 130 years ago, Leem now has nearly 270 member companies, which generate nearly 98% of the total pharmaceutical turnover in France. The pharmaceutical industry employs 100,000 people in over 150 professions, and has recruited 10,000 employees per year for the past 10 years. Each year, the pharmaceutical industry invests 12% of its turnover in research, in order to develop new innovative treatments. It brings together more than 20,000 people in its … Sectors: Startup accelerator & VC | 721 | 384 | 261 | |
Gilead Sciences Creating Possible At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines Sectors: Biotechnology Pharmaceutical | 806 | 622 | 70 | |
Novo Nordisk Driving change to defeat serious chronic diseases, built upon our heritage in diabetes. Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 66,000 people in 80 countries and markets its products in around 170 countries. For more information visit novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments … Sectors: Pharmaceutical | 1360 | 1110 | 144 | |
ESPCI Paris - PSL [Automatic translation follows] Engineering school, research and innovation center - #HRS4R label - Component of PSL University ESPCI Paris – PSL (École Supérieure de Physique et de Chimie Industrielles de la Ville de Paris) is a general engineering school that has been training disruptive, adaptable and creative engineers since 1882, with a solid theoretical and experimental background, aware of the challenges facing society. It is part of an internationally recognized research center in physics, chemistry and biology (500 publications per year). It is known for its ability to transform knowledge from fundamental research into breakthrough innovations (2 patents per month, … Sectors: Startup accelerator & VC | 167 | 102 | 73 | |
AbbVie AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html. Biopharmaceutical, Biotechnology, Innovation, Research and Development, Manufacturing, Biotherapeutics, Oncology, Immunology, Virology, Neuroscience, Womens Health, Aesthetics, and Eye Care Sectors: Pharmaceutical | 941 | 772 | 130 | |
Bristol Myers Squibb At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, … Sectors: Pharmaceutical | 1661 | 1074 | 127 |